PortfoliosLab logoPortfoliosLab logo
QMCO vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

QMCO vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quantum Corporation (QMCO) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, QMCO achieves a 64.96% return, which is significantly higher than ABBV's 12.42% return. Over the past 10 years, QMCO has underperformed ABBV with an annualized return of -20.32%, while ABBV has yielded a comparatively higher 18.94% annualized return.


QMCO

1D
-5.34%
1M
4.72%
6M
71.61%
YTD
64.96%
1Y
41.30%
3Y*
-23.10%
5Y*
-38.81%
10Y*
-20.32%
ALL TIME*
-18.32%

ABBV

1D
-2.51%
1M
-3.20%
6M
14.27%
YTD
12.42%
1Y
32.53%
3Y*
23.28%
5Y*
20.99%
10Y*
18.94%
ALL TIME*
20.35%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$1.40B$1.53B$1.60B
$10.63M$9.59M$13.73M

QMCO vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
QMCO
Quantum Corporation
64.96%-88.04%672.49%-67.98%-80.25%-9.80%-17.52%271.00%-64.48%-15.42%
ABBV
AbbVie Inc.
12.42%33.08%18.86%-0.23%24.01%32.43%27.72%1.47%-0.96%60.07%

Correlation

The correlation between QMCO and ABBV is -0.12, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

-0.12

Correlation (3Y)
Balances recent behavior with more history.

0.01

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.02

Correlation (10Y)
Provides a long-term view across more market conditions.

0.06

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2013

0.10

The correlation between QMCO and ABBV shifts across timeframes, from -0.12 (1 year) to 0.10 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

QMCO:

$66.49M

ABBV:

$443.24B

EPS

QMCO:

-$7.68

ABBV:

$2.05

PS Ratio

QMCO:

0.50

ABBV:

7.08

Total Revenue (TTM)

QMCO:

$279.58M

ABBV:

$62.82B

Gross Profit (TTM)

QMCO:

$103.04M

ABBV:

$46.15B

EBITDA (TTM)

QMCO:

-$67.70M

ABBV:

$17.96B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

QMCO vs. ABBV — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

QMCO
QMCO Risk / Return Rank: 6060
Overall Rank
QMCO Sharpe Ratio Rank: 5757
Sharpe Ratio Rank
QMCO Sortino Ratio Rank: 6666
Sortino Ratio Rank
QMCO Omega Ratio Rank: 6262
Omega Ratio Rank
QMCO Calmar Ratio Rank: 5757
Calmar Ratio Rank
QMCO Martin Ratio Rank: 5656
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 8181
Overall Rank
ABBV Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 8282
Sortino Ratio Rank
ABBV Omega Ratio Rank: 8080
Omega Ratio Rank
ABBV Calmar Ratio Rank: 8080
Calmar Ratio Rank
ABBV Martin Ratio Rank: 7979
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

QMCO vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Quantum Corporation (QMCO) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


QMCOABBVDifference
Sharpe ratioReturn per unit of total volatility

-1.10

Sortino ratioReturn per unit of downside risk

-0.84

Omega ratioGain probability vs. loss probability

1.15

1.26

-0.12

Calmar ratioReturn relative to maximum drawdown

0.49

2.14

-1.65

Martin ratioReturn relative to average drawdown

0.85

4.73

-3.89

QMCO vs. ABBV - Sharpe Ratio Comparison

The current QMCO Sharpe Ratio is 0.32, which is lower than the ABBV Sharpe Ratio of 1.42. The chart below compares the historical Sharpe Ratios of QMCO and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

QMCO vs. ABBV - Drawdown Comparison

The maximum QMCO drawdown since its inception was -99.93%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for QMCO and ABBV.


Loading charts...

Drawdown Indicators


QMCOABBVDifference

Max Drawdown

Largest peak-to-trough decline

-99.93%

-45.09%

-54.84%

Max Drawdown (1Y)

Largest decline over 1 year

-67.72%

-17.32%

-50.40%

Max Drawdown (3Y)

Largest decline over 3 years

-93.90%

-20.74%

-73.16%

Max Drawdown (5Y)

Largest decline over 5 years

-98.26%

-21.92%

-76.34%

Max Drawdown (10Y)

Largest decline over 10 years

-98.67%

-45.09%

-53.58%

Current Drawdown

Current decline from peak

-99.69%

-4.69%

-95.00%

Average Drawdown

Average peak-to-trough decline

-88.14%

-10.64%

-77.50%

Ulcer Index

Depth and duration of drawdowns from previous peaks

38.82%

7.81%

+31.01%

Volatility

QMCO vs. ABBV - Volatility Comparison

Quantum Corporation (QMCO) has a higher volatility of 23.03% compared to AbbVie Inc. (ABBV) at 8.35%. This indicates that QMCO's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


QMCOABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

23.03%

8.35%

+14.68%

Volatility (6M)

Calculated over the trailing 6-month period

74.53%

19.56%

+54.97%

Volatility (1Y)

Calculated over the trailing 1-year period

104.69%

26.14%

+78.55%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

159.82%

23.46%

+136.36%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

124.86%

25.92%

+98.94%

Dividends

QMCO vs. ABBV - Dividend Comparison

QMCO has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 2.72%.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
2.72%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
QMCO
Quantum Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

QMCO vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between Quantum Corporation and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

QMCO vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Quantum Corporation and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

QMCO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Quantum Corporation reported a gross profit of 27.85M and revenue of 77.99M. Therefore, the gross margin over that period was 35.7%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.

QMCO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Quantum Corporation reported an operating income of -4.09M and revenue of 77.99M, resulting in an operating margin of -5.2%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.

QMCO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Quantum Corporation reported a net income of -9.54M and revenue of 77.99M, resulting in a net margin of -12.2%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.


Frequently Asked Questions


QMCO and ABBV have a correlation of -0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

QMCO has higher volatility (23.03%) compared to ABBV (8.35%). In terms of maximum drawdown, QMCO dropped -99.93% vs ABBV's -45.09%.

ABBV currently has the higher Sharpe Ratio (1.42 vs 0.32), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for QMCO and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer